CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test
Test Name: CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CACNA1D Gene Sinoatrial Node Dysfunction and Deafness NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Sinoatrial Node Dysfunction and Deafness NGS Genetic DNA Test gene CACNA1D
Test Details: The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the electrical conduction system of the heart, specifically affecting the sinoatrial node, which is responsible for initiating the heart’s electrical signals. This dysfunction can lead to irregular heart rhythms, such as bradycardia (slow heart rate) or sinus arrest (pauses in the heart’s electrical activity). Deafness, on the other hand, refers to partial or complete loss of hearing. Mutations in the CACNA1D gene have been linked to a specific form of deafness called autosomal dominant non-syndromic hearing loss type 23 (DFNA23). This type of hearing loss typically begins in late childhood or early adulthood and affects both ears equally.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with specific conditions. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction or deafness. This information can then be used for diagnosis, prognosis, and potentially guiding treatment decisions.
| Test Name | CACNA1D Gene Sinoatrial node dysfunction and deafness Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CACNA1D Gene Sinoatrial node dysfunction and deafness NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Sinoatrial node dysfunction and deafness NGS Genetic DNA Test gene CACNA1D |
| Test Details | The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the electrical conduction system of the heart, specifically affecting the sinoatrial node, which is responsible for initiating the heart’s electrical signals. This dysfunction can lead to irregular heart rhythms, such as bradycardia (slow heart rate) or sinus arrest (pauses in the heart’s electrical activity). Deafness, on the other hand, refers to partial or complete loss of hearing. Mutations in the CACNA1D gene have been linked to a specific form of deafness called autosomal dominant non-syndromic hearing loss type 23 (DFNA23). This type of hearing loss typically begins in late childhood or early adulthood and affects both ears equally. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with specific conditions. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction or deafness. This information can then be used for diagnosis, prognosis, and potentially guiding treatment decisions. |
